Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1sze | 173 | Cytochrome b2, mitochondrial | 1.1.2.3 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 1sze | 173 | Cytochrome b2, mitochondrial | 1.1.2.3 | 1.000 | |
| 3bgx | MEF | Thymidylate synthase | / | 0.487 | |
| 2fto | CB3 | Thymidylate synthase | / | 0.485 | |
| 3bgx | TMP | Thymidylate synthase | / | 0.473 | |
| 1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.471 | |
| 1tys | DHF | Thymidylate synthase | / | 0.469 | |
| 3bhr | THG | Thymidylate synthase | / | 0.468 | |
| 3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.468 | |
| 1fwm | CB3 | Thymidylate synthase | / | 0.465 | |
| 4ku5 | DCC | 3-oxoacyl-[ACP] synthase III | / | 0.462 | |
| 2cvz | NDP | 3-hydroxyisobutyrate dehydrogenase | / | 0.461 | |
| 4o7u | THF | Thymidylate synthase | / | 0.461 | |
| 1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.460 | |
| 1ci7 | UMP | Thymidylate synthase | 2.1.1.45 | 0.459 | |
| 4oew | 5IO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.459 | |
| 4lsa | BLD | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.458 | |
| 1w7k | ADP | Dihydrofolate synthase/folylpolyglutamate synthase | 6.3.2.12 | 0.457 | |
| 3ufl | 508 | Beta-secretase 1 | 3.4.23.46 | 0.457 | |
| 4cax | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.457 | |
| 1tdu | DUR | Thymidylate synthase | / | 0.456 | |
| 2fto | TMP | Thymidylate synthase | / | 0.454 | |
| 3qpp | PFW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.454 | |
| 3h4v | NAP | Pteridine reductase 1 | 1.5.1.33 | 0.453 | |
| 4b5n | FMN | NAD(P)H:flavin oxidoreductase Sye4 | / | 0.453 | |
| 4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
| 5bp9 | SAH | Putative methyltransferase protein | / | 0.453 | |
| 4pnm | NU1 | Tankyrase-2 | 2.4.2.30 | 0.452 | |
| 4jd3 | COA | Alpha-pyrone synthesis polyketide synthase-like Pks11 | 2.3.1 | 0.451 | |
| 4glx | 0XS | DNA ligase | 6.5.1.2 | 0.450 | |
| 3bhl | THG | Thymidylate synthase | / | 0.449 | |
| 1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.448 | |
| 3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.448 | |
| 3v94 | WYQ | Phosphodiesterase | / | 0.448 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.448 | |
| 2zu9 | GDP | Mannosyl-3-phosphoglycerate synthase | 2.4.1.217 | 0.447 | |
| 3dh7 | FMN | Isopentenyl-diphosphate delta-isomerase | / | 0.447 | |
| 3l5b | BDO | Beta-secretase 1 | 3.4.23.46 | 0.447 | |
| 3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
| 3zw9 | NAD | Peroxisomal bifunctional enzyme | 1.1.1.35 | 0.447 | |
| 4ez8 | DHF | Thymidylate synthase | 2.1.1.45 | 0.447 | |
| 4knz | CB3 | Thymidylate synthase | / | 0.447 | |
| 1eji | THF | Serine hydroxymethyltransferase, cytosolic | / | 0.446 | |
| 1kzj | CB3 | Thymidylate synthase | / | 0.446 | |
| 5ab6 | CAA | Nonspecific lipid-transfer protein, putative | / | 0.446 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.445 | |
| 4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
| 4msg | 2C6 | Tankyrase-1 | 2.4.2.30 | 0.445 | |
| 1fdt | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.444 | |
| 1tys | TMP | Thymidylate synthase | / | 0.444 | |
| 3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
| 1dfo | FFO | Serine hydroxymethyltransferase | 2.1.2.1 | 0.443 | |
| 1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 1upw | 444 | Oxysterols receptor LXR-beta | / | 0.443 | |
| 3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
| 4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
| 2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
| 2zru | FMN | Isopentenyl-diphosphate delta-isomerase | / | 0.442 | |
| 4nmd | FDA | Bifunctional protein PutA | / | 0.442 | |
| 1s7g | NAD | NAD-dependent protein deacylase 2 | / | 0.441 | |
| 1yc2 | NAD | NAD-dependent protein deacylase 2 | / | 0.441 | |
| 3bgr | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
| 4rw6 | 494 | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
| 1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
| 1pt8 | ACO | Formyl-CoA:oxalate CoA-transferase | / | 0.440 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.440 | |
| 2c59 | NAD | GDP-mannose 3,5-epimerase | 5.1.3.18 | 0.440 | |
| 4eil | UMP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.440 | |
| 4phl | PIL | Phosphodiesterase | / | 0.440 | |
| 5a3b | APR | SIR2 family protein | / | 0.440 | |
| 5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 |